Variant report

Variant	esv3368359
Chromosome Location	chr2:114340182-114360880
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2116)
CpG islands
(count:915)
Chromatin interactive
region (count:4)
LncRNA
region (count:17)
Mature miRNA
region (count: 1)
miRNA target
sites (count:0)

(count:2116 , 50 per page) page: 1 2 3 4 5 6 7 ... 43

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:114341464-114341790	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:114340115-114340374	K562	blood:	n/a	n/a
3	ARID3A	chr2:114341528-114341709	K562	blood:	n/a	n/a
4	ATF1	chr2:114340089-114340480	K562	blood:	n/a	n/a
5	ATF1	chr2:114349732-114349772	K562	blood:	n/a	n/a
6	ATF2	chr2:114341413-114341806	GM12878	blood:	n/a	n/a
7	ATF2	chr2:114341425-114341694	H1-hESC	embryonic stem cell:	n/a	n/a
8	ATF3	chr2:114341420-114341810	A549	lung:	n/a	n/a
9	ATF3	chr2:114359657-114359767	GM12878	blood:	n/a	n/a
10	ATF3	chr2:114341426-114341722	A549	lung:	n/a	n/a
11	ATF3	chr2:114359628-114359819	H1-hESC	embryonic stem cell:	n/a	n/a
12	ATF3	chr2:114359653-114359828	K562	blood:	n/a	n/a
13	ATF3	chr2:114359623-114359862	GM12878	blood:	n/a	n/a
14	BACH1	chr2:114342450-114342472	H1-hESC	embryonic stem cell:	n/a	n/a
15	BATF	chr2:114356527-114356738	GM12878	blood:	n/a	n/a
16	BATF	chr2:114353823-114353988	GM12878	blood:	n/a	n/a
17	BATF	chr2:114354654-114354853	GM12878	blood:	n/a	n/a
18	BATF	chr2:114359584-114359759	GM12878	blood:	n/a	n/a
19	BATF	chr2:114359080-114359259	GM12878	blood:	n/a	n/a
20	BATF	chr2:114359457-114359883	GM12878	blood:	n/a	n/a
21	BATF	chr2:114340791-114341141	GM12878	blood:	n/a	n/a
22	BATF	chr2:114342145-114342363	GM12878	blood:	n/a	n/a
23	BATF	chr2:114341927-114342368	GM12878	blood:	n/a	n/a
24	BATF	chr2:114356769-114357086	GM12878	blood:	n/a	n/a
25	BATF	chr2:114356797-114357011	GM12878	blood:	n/a	n/a
26	BATF	chr2:114358733-114359308	GM12878	blood:	n/a	n/a
27	BATF	chr2:114342934-114343135	GM12878	blood:	n/a	n/a
28	BATF	chr2:114343300-114343492	GM12878	blood:	n/a	chr2:114343416-114343427
29	BATF	chr2:114340809-114341094	GM12878	blood:	n/a	n/a
30	BATF	chr2:114357543-114357728	GM12878	blood:	n/a	n/a
31	BATF	chr2:114341254-114341925	GM12878	blood:	n/a	n/a
32	BCL11A	chr2:114357078-114358032	GM12878	blood:	n/a	n/a
33	BCL11A	chr2:114356546-114357018	GM12878	blood:	n/a	n/a
34	BCL11A	chr2:114341277-114342392	GM12878	blood:	n/a	chr2:114341890-114341903 chr2:114341855-114341868 chr2:114341592-114341601 chr2:114341601-114341614 chr2:114341854-114341867
35	BCL11A	chr2:114357565-114358027	GM12878	blood:	n/a	n/a
36	BCL11A	chr2:114344807-114345018	GM12878	blood:	n/a	n/a
37	BCL11A	chr2:114353154-114353342	GM12878	blood:	n/a	n/a
38	BCL11A	chr2:114351607-114351786	GM12878	blood:	n/a	n/a
39	BCL11A	chr2:114351923-114352092	GM12878	blood:	n/a	n/a
40	BCL11A	chr2:114348919-114349101	GM12878	blood:	n/a	n/a
41	BCL11A	chr2:114359452-114359825	GM12878	blood:	n/a	n/a
42	BCL11A	chr2:114340779-114341050	GM12878	blood:	n/a	n/a
43	BCL11A	chr2:114346548-114346720	GM12878	blood:	n/a	n/a
44	BCL11A	chr2:114356590-114356954	GM12878	blood:	n/a	n/a
45	BCL11A	chr2:114347973-114348302	GM12878	blood:	n/a	n/a
46	BCL11A	chr2:114354623-114354871	GM12878	blood:	n/a	n/a
47	BCL11A	chr2:114359458-114359824	GM12878	blood:	n/a	n/a
48	BCL11A	chr2:114358093-114358502	GM12878	blood:	n/a	n/a
49	BCL11A	chr2:114349921-114350176	GM12878	blood:	n/a	n/a
50	BCL11A	chr2:114358372-114359354	GM12878	blood:	n/a	n/a

(count:915 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:114342108-114342158	HUVEC	blood vessel:	n/a
2	chr2:114345644-114345694	ovcar-3	ovarian:	n/a
3	chr2:114359762-114359812	HCPEpiC	choroid plexus:	n/a
4	chr2:114357261-114357311	AoSMC	blood vessel:	n/a
5	chr2:114359762-114359812	NHBE	bronchial:	n/a
6	chr2:114342621-114342671	ECC-1	luminal epithelium:	n/a
7	chr2:114360096-114360146	U87	brain:	n/a
8	chr2:114345644-114345694	MCF10A-Er-Src	breast:	n/a
9	chr2:114359736-114359786	Hela-S3	cervix:	n/a
10	chr2:114359251-114359301	MCF10A-Er-Src	breast:	n/a
11	chr2:114341631-114341681	MCF-7	breast:	n/a
12	chr2:114340391-114340441	BJ	skin:	n/a
13	chr2:114359762-114359812	HMEC	breast:	n/a
14	chr2:114359188-114359238	NT2-D1	testis:	n/a
15	chr2:114342108-114342158	ECC-1	luminal epithelium:	n/a
16	chr2:114341680-114341730	T-47D	breast:	n/a
17	chr2:114359762-114359812	HCM	heart:	n/a
18	chr2:114359188-114359238	MCF10A-Er-Src	breast:	n/a
19	chr2:114359762-114359812	HPAEpiC	pulmonary alveolar:	n/a
20	chr2:114359251-114359301	HepG2	liver:	n/a
21	chr2:114360096-114360146	HIPEpiC	eye:	n/a
22	chr2:114341680-114341730	NHDF-neo	bronchial:	n/a
23	chr2:114341111-114341161	RPTEC	kidney:	n/a
24	chr2:114359251-114359301	ovcar-3	ovarian:	n/a
25	chr2:114359873-114359923	GM06990	blood:	n/a
26	chr2:114341631-114341681	GM19239	blood:	n/a
27	chr2:114360096-114360146	AG09309	skin:	n/a
28	chr2:114340391-114340441	PFSK-1	brain:	n/a
29	chr2:114341111-114341161	HCM	heart:	n/a
30	chr2:114341680-114341730	HRPEpiC	eye:	n/a
31	chr2:114357261-114357311	SAEC	small airway:	n/a
32	chr2:114346218-114346268	PFSK-1	brain:	n/a
33	chr2:114360096-114360146	Hepatocyte	liver:	n/a
34	chr2:114359251-114359301	HMEC	breast:	n/a
35	chr2:114341111-114341161	HCT-116	colon:	n/a
36	chr2:114342108-114342158	HCPEpiC	choroid plexus:	n/a
37	chr2:114342108-114342158	SAEC	small airway:	n/a
38	chr2:114359251-114359301	HCF	heart:	n/a
39	chr2:114340391-114340441	NT2-D1	testis:	n/a
40	chr2:114341111-114341161	GM06990	blood:	n/a
41	chr2:114359736-114359786	HPAEpiC	pulmonary alveolar:	n/a
42	chr2:114342108-114342158	AG04450	lung:	fetal
43	chr2:114345644-114345694	LNCaP	prostate:	n/a
44	chr2:114340391-114340441	HCT-116	colon:	n/a
45	chr2:114345644-114345694	HEEpiC	esophagus:	n/a
46	chr2:114342108-114342158	HMEC	breast:	n/a
47	chr2:114341680-114341730	ovcar-3	ovarian:	n/a
48	chr2:114359762-114359812	HEK293	kidney:	embryo
49	chr2:114341680-114341730	MCF10A-Er-Src	breast:	n/a
50	chr2:114359188-114359238	AoSMC	blood vessel:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:114359257..114359811-chr2:114457510..114458087,2	MCF-7	breast:
2	chr12:77501..78029-chr2:114344484..114344991,2	MCF-7	breast:
3	chr2:114344560..114345063-chr2:114361338..114362244,2	MCF-7	breast:
4	chr12:77529..78029-chr2:114344487..114344997,2	MCF-7	breast:

(count:17 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLC35F5-16	chr2:114358319-114358403	NONHSAT073812
2	lnc-SLC35F5-16	chr2:114358789-114359006	NONHSAT073809
3	lnc-SLC35F5-16	chr2:114357939-114358040	NONHSAT073812
4	lnc-SLC35F5-17	chr2:114347802-114348156	l_1931_chr2:114347801-114356084_testes
5	lnc-SLC35F5-16	chr2:114358789-114359153	NONHSAT073810
6	lnc-SLC35F5-16	chr2:114356605-114358421	NONHSAT073809
7	lnc-SLC35F5-16	chr2:114356605-114358403	NONHSAT073811
8	lnc-SLC35F5-17	chr2:114349194-114349311	l_1931_chr2:114347801-114356084_testes
9	lnc-SLC35F5-16	chr2:114358295-114358403	NONHSAT073810
10	lnc-SLC35F5-16	chr2:114358319-114358403	NONHSAT073813
11	lnc-SLC35F5-16	chr2:114356613-114357773	NONHSAT073812
12	lnc-SLC35F5-16	chr2:114358789-114359153	NONHSAT073811
13	lnc-SLC35F5-16	chr2:114358789-114358838	NONHSAT073812
14	lnc-SLC35F5-16	chr2:114356605-114357791	NONHSAT073810
15	lnc-SLC35F5-17	chr2:114355758-114356084	l_1931_chr2:114347801-114356084_testes
16	lnc-SLC35F5-16	chr2:114358789-114358838	NONHSAT073813
17	lnc-SLC35F5-16	chr2:114356613-114357795	NONHSAT073813

miRNA name	Chromosome Location	mirBase accession
hsa-miR-1302	chr2:114340581-114340601	MIMAT0005890_4

No data

Variant related genes	Relation type
DDX11L2	TF binding region
WASH2P	TF binding region
MIR1302-3	TF binding region
DDX11L2	CpG island
WASH2P	CpG island
MIR1302-3	CpG island

Extended variants
information (count: 1030 )
Associated
traits (count: 54 )

Variant overlapped rSNPs/rCNVs (count:1030 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs146352538	chr2:114340184-114340185	Enhancers Weak transcription Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs201357035	chr2:114340231-114340232	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs11491267	chr2:114340245-114340246	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs8179743	chr2:114340258-114340259	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs7602522	chr2:114340260-114340261	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs551960059	chr2:114340276-114340277	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs536197	chr2:114340311-114340312	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs536055	chr2:114340367-114340368	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs111245088	chr2:114340376-114340377	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs571893606	chr2:114340382-114340383	Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs527967951	chr2:114340430-114340431	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs6542146	chr2:114340433-114340434	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs191134229	chr2:114340440-114340441	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs144719550	chr2:114340451-114340452	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs7561824	chr2:114340454-114340455	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs543698950	chr2:114340467-114340468	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs567247847	chr2:114340472-114340473	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs7349209	chr2:114340494-114340495	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs11123198	chr2:114340511-114340512	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs2441621	chr2:114340615-114340616	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs7589328	chr2:114340628-114340629	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs74625964	chr2:114340631-114340632	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs6542147	chr2:114340663-114340664	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs6542148	chr2:114340677-114340678	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs2258969	chr2:114340706-114340707	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs370472644	chr2:114340707-114340708	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs555750020	chr2:114340745-114340746	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs7349443	chr2:114340786-114340787	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs142620574	chr2:114340787-114340788	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs563993698	chr2:114340809-114340810	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs538367528	chr2:114340814-114340815	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs434519	chr2:114340854-114340855	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs558295413	chr2:114340872-114340873	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs28743045	chr2:114340892-114340893	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs572182913	chr2:114340963-114340964	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs200629995	chr2:114340974-114340975	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs28451476	chr2:114341002-114341003	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs2475479	chr2:114341011-114341012	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs182663343	chr2:114341051-114341052	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs2418687	chr2:114341074-114341075	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs2418689	chr2:114341100-114341101	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs541297954	chr2:114341115-114341116	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
43	rs28757822	chr2:114341129-114341130	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
44	rs11491268	chr2:114341145-114341146	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
45	rs74742233	chr2:114341158-114341159	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
46	rs2418690	chr2:114341172-114341173	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs2418691	chr2:114341190-114341191	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs2418692	chr2:114341216-114341217	Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs554614802	chr2:114341217-114341218	Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs187314072	chr2:114341219-114341220	Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:54)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Colorectal cancer	16912164	CNVD
Ischaemic stroke	16980335	CNVD
Acute myeloid leukemia	18000384	CNVD
Nephronophthisis	17901113	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD

Chromatin state (count:978 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:114311400-114340400	Weak transcription	Fetal Stomach	stomach
2	chr2:114329600-114341000	Weak transcription	NHDF-Ad	bronchial
3	chr2:114333200-114340200	Weak transcription	Primary monocytes fromperipheralblood	blood
4	chr2:114334800-114340200	Weak transcription	Fetal Muscle Leg	muscle
5	chr2:114336600-114340200	Enhancers	K562	blood
6	chr2:114336800-114340200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
7	chr2:114337000-114340200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr2:114339000-114340200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
9	chr2:114339200-114340200	Weak transcription	NHLF	lung
10	chr2:114340000-114340200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
11	chr2:114340000-114340200	Active TSS	Breast Myoepithelial Primary Cells	Breast
12	chr2:114340000-114340200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
13	chr2:114340000-114340200	Enhancers	Fetal Kidney	kidney
14	chr2:114340000-114340200	Enhancers	Dnd41	blood
15	chr2:114340000-114340600	Bivalent Enhancer	HepG2	liver
16	chr2:114340000-114340800	Enhancers	Monocytes-CD14+_RO01746	blood
17	chr2:114340000-114341000	Enhancers	Duodenum Smooth Muscle	Duodenum
18	chr2:114340000-114341000	Enhancers	Fetal Muscle Trunk	muscle
19	chr2:114340000-114341000	Enhancers	Placenta	Placenta
20	chr2:114340000-114341000	Enhancers	HSMMtube	muscle
21	chr2:114340000-114341200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
22	chr2:114340200-114340400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
23	chr2:114340200-114340400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
24	chr2:114340200-114340400	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
25	chr2:114340200-114340400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
26	chr2:114340200-114340400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr2:114340200-114340400	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
28	chr2:114340200-114340400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
29	chr2:114340200-114340400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr2:114340200-114340400	Bivalent Enhancer	Brain Cingulate Gyrus	brain
31	chr2:114340200-114340400	Enhancers	Brain Substantia Nigra	brain
32	chr2:114340200-114340400	Enhancers	Placenta Amnion	Placenta Amnion
33	chr2:114340200-114340400	Enhancers	Small Intestine	intestine
34	chr2:114340200-114340400	Enhancers	Thymus	Thymus
35	chr2:114340200-114340400	Enhancers	NHEK	skin
36	chr2:114340200-114340400	Enhancers	NHLF	lung
37	chr2:114340200-114340600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
38	chr2:114340200-114340600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
39	chr2:114340200-114340600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr2:114340200-114340600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr2:114340200-114340600	Flanking Active TSS	Fetal Kidney	kidney
42	chr2:114340200-114340800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr2:114340200-114340800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
44	chr2:114340200-114340800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr2:114340200-114340800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr2:114340200-114340800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr2:114340200-114340800	Enhancers	Fetal Lung	lung
48	chr2:114340200-114340800	Enhancers	HMEC	breast
49	chr2:114340200-114340800	Flanking Active TSS	K562	blood
50	chr2:114340200-114341000	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links